News Focus
News Focus
Followers 37
Posts 3491
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Tuesday, 03/31/2026 5:42:16 AM

Tuesday, March 31, 2026 5:42:16 AM

Post# of 971
At ASGCT '25, Fate presented preclinical data on targeting uPAR with a multiplexed-engineered CAR-T to reverse age- and insult-related fibrotic disease. Now this has just been published https://medicalxpress.com/news/2026-03-upar-car-cells-shrank-solid.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News